Magellan Rx Management is closely monitoring developments related to coronavirus (COVID-19), including yesterday’s presidential press conference.
In partnership with their key strategic partners and a multi-disciplinary team of corporate executives and clinicians, Magellan is actively engaging and monitoring for potential impact to the drug supply chain through a variety of external channels, including:
- U.S. Food & Drug Administration (FDA) – tracking the FDA’s shortage risks across the overall national supply chain through our dedicated MRx Drug Availability Surveillance Committee.
- American Society of Health-System Pharmacists (ASHP) – observing the ASHP real-time drug shortages for information on drugs and availability.
- Wholesale partners – understanding their monitoring of raw materials and ability to source increased product supplies ahead of potential impact.
- Pharmaceutical manufacturers – directly communicating with manufacturers to obtain insight on potential supply chain risks.
- Retail pharmacies – directly working with our retail network pharmacies on the status of their supply chain.
Every area of Magellan’s business is monitoring COVID-19, and they are positioned internally to gauge impact to the supply chain and triage accordingly through:
- MRx home delivery and specialty pharmacies – ordering and receiving daily drug products and adjusting ordering strategies to ensure they are best prepared to meet their demand.
- Clinical expertise – in the event of a shortage, they are poised to identify a therapeutic alternative and address formulary implications to protect members from out-of-pocket cost increases.
- Provider relations team – monitoring and ready to triage calls from providers and/or members regarding shortage or hoarding issues.
In a press conference on March 19, the President described work by the FDA and researchers on treatments for COVID-19, specifically highlighting the use of chloroquine. In the FDA’s press release more details about plans regarding chloroquine can be found.
It is important to remember that the Federal, State and community guidance around coronavirus (COVID-19) is evolving rapidly and Magellan is committed to taking necessary action and keeping you informed.
Source: https://www1.magellanrx.com/coronavirus-covid-19-update/
